Biomarkers & Translational Medicine | Nucleate Translate Session 2 | 2023

Learn about the definition, importance, and development process for validated clinical biomarkers from Dr. John Wagner, Chief Medical Officer of Koneska. Listeners will come away with:
- An understanding of biomarkers and their role in expediting drug development
- A framework for biomarker discovery, development, and analytical validation
Nucleate Translate is an open-access lecture series by physicians to help future biotech leaders understand the fundamentals of clinical development and how to make a positive impact on clinical practice. Co-founded by Sayo Eweje ([e-mail]) & Julia Pian, MD, MBA ([e-mail]), Co-VPs of Clinical Operations in 2023.
Session 1: Unmet Needs & Indication Selection | Dr. Catherine Stehman-Breen, CEO of Chroma Medicines | tinyurl.com/32batudx
Session 2: Biomarkers and Translation Medicine | Dr. John Wagner, CMO Koneksa | tinyurl.com/4uvn4x95
Session 3: Interactions with Regulatory Agencies | Dr. Mwango Kashoki, VP of Regulatory Affairs at Parexel International | tinyurl.com/4nh4us52
Session 4: Physicians in Biotech Panel | feat. Drs. Jay Bradner, Shehnaaz Suliman, and Akshay Vaishnaw | tinyurl.com/2s4dvy9p
Session 5: Designing & Conducting Clinical Trials | Dr. Serena Hung, CMO of Arkuda Therapeutics | tinyurl.com/2s4dvy9p
Connect with Nucleate | nucleate.xyz | / nucleatehq | / nucleatehq
About Our Speaker
Dr. John A. Wagner, M.D., Ph.D., oversees clinical investment and strategy at Koneksa. With more than 20 years of drug development experience, Dr. Wagner has led more than 150 first-in-human studies and has been instrumental in bringing numerous blockbuster programs to market. Prior to joining Koneksa, John was CMO of Cygnal Therapeutics, held senior leadership roles at Takeda and Merck, and was a venture partner at Foresite Capital. In addition, John is editor-in-chief of Clinical and Translational Science and an executive committee member of the Foundation for the National Institutes of Health Biomarkers Consortium.
#biotech #physicians